Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St Joseph Mercy Hospital
mi
from
Ypsilanti, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St Joseph Mercy Hospital
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
North Memorial Medical Center
mi
from
Minneapolis, MN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
North Memorial Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Mercy Hospital
mi
from
Minneapolis, MN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Mercy Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Paul Heart Clinic
mi
from
St. Paul, MN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Paul Heart Clinic
mi
from
St. Paul, MN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Southern Heart Center
mi
from
Hattiesburg, MS
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Southern Heart Center
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Jackson Heart Clinic
mi
from
Jackson, MS
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Jackson Heart Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
ST. Luke's Hospital
mi
from
Kansas City, MO
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
ST. Luke's Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
North Kansas City Hospital
mi
from
North Kansas City, MO
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
North Kansas City Hospital
mi
from
North Kansas City, MO
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. John's Research Institute, Inc., St. John's Hospital
mi
from
Springfield, MO
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. John's Research Institute, Inc., St. John's Hospital
mi
from
Springfield, MO
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Billings Clinic Research Center
mi
from
Billings, MT
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Billings Clinic Research Center
mi
from
Billings, MT
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Dartmouth-Hitchock Medical Center
mi
from
Lebanon, NH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Dartmouth-Hitchock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Hackensack Medical Center
mi
from
Hackensack, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Hackensack Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
CADV
mi
from
Haddon Heights, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
CADV
mi
from
Haddon Heights, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Joseph's Regional Medical Center
mi
from
Paterson, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Joseph's Regional Medical Center
mi
from
Paterson, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
The Valley Hospital
mi
from
Ridgewood, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Peter's Hospital
mi
from
Albany, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Peter's Hospital
mi
from
Albany, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Jack D. Weiler Hospital of Montefiore Medical Center
mi
from
Bronx, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Jack D. Weiler Hospital of Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Buffalo Heart Group, LLC
mi
from
Buffalo, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Buffalo Heart Group, LLC
mi
from
Buffalo, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Mount Sinai Medical Center
mi
from
NY, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Mount Sinai Medical Center
mi
from
NY, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Rochester Cardiopulmonary Group
mi
from
Rochester, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Rochester Cardiopulmonary Group
mi
from
Rochester, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Stony Brook Hospital and Medical Center
mi
from
Stony Brook, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Stony Brook Hospital and Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Joseph's Hospital Health Center
mi
from
Syracuse, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Joseph's Hospital Health Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Carolinas Medical Center
mi
from
Charlotte, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Mid Carolina Cardiology
mi
from
Charlotte, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Mid Carolina Cardiology
mi
from
Charlotte, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Gaston Memorial Hospital
mi
from
Gastonia, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Gaston Memorial Hospital
mi
from
Gastonia, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
High Point Regional Health System
mi
from
High Point, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
High Point Regional Health System
mi
from
High Point, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
WakeMed Hospital
mi
from
Raleigh, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
WakeMed Hospital
mi
from
Raleigh, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Forsyth Medical Center
mi
from
Winston-Salem, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Forsyth Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Altru Health System
mi
from
Grand Forks, ND
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Altru Health System
mi
from
Grand Forks, ND
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
The Christ Hospital
mi
from
Cincinnati, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
North Ohio Research LTD, Elyria Regional Medical Center
mi
from
Elyria, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
North Ohio Research LTD, Elyria Regional Medical Center
mi
from
Elyria, OH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Fairview Hospital
mi
from
Fairview Park, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Fairview Hospital
mi
from
Fairview Park, OH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Toledo Hospital / Jobst Vascular Center
mi
from
Toledo, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Toledo Hospital / Jobst Vascular Center
mi
from
Toledo, OH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Vincent Mercy Medical Center
mi
from
Toledo, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Vincent Mercy Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Cardiology Associates Of Southeastern Ohio
mi
from
Zanesville, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Cardiology Associates Of Southeastern Ohio
mi
from
Zanesville, OH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Midwest Regional Medical Center
mi
from
Midwest City, OK
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Midwest Regional Medical Center
mi
from
Midwest City, OK
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Integris-Baptist Medical
mi
from
Oklahoma City, OK
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Integris-Baptist Medical
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Hillcrest Medical Center
mi
from
Tulsa, OK
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Hillcrest Medical Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Sacred Heart Medical Center
mi
from
Eugene, OR
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Sacred Heart Medical Center
mi
from
Eugene, OR
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Abington Memorial Hospital
mi
from
Abington, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Tri-State Medical Group
mi
from
Beaver, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Tri-State Medical Group
mi
from
Beaver, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Franklin County Heart Center at Summit Cardiology
mi
from
Chambersburg, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Franklin County Heart Center at Summit Cardiology
mi
from
Chambersburg, PA
Click here to add this to my saved trials